Corcept Therapeutics Incorporated (CORT)

Operating return on assets (Operating ROA)

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating income	US$ in thousands	107,282	112,634	124,477	128,202	111,606
Total assets	US$ in thousands	621,517	583,430	423,756	571,731	412,312
Operating ROA		17.26%	19.31%	29.37%	22.42%	27.07%

December 31, 2023 calculation

Operating ROA = Operating income ÷ Total assets
= $107,282K ÷ $621,517K
= 17.26%

Corcept Therapeutics Inc's operating return on assets (operating ROA) has shown fluctuation over the past five years. In 2021, the company achieved a high operating ROA of 29.37%, indicating that for every dollar of assets, Corcept generated a return of 29.37% from its operations. This high performance suggests efficient asset utilization and strong operational profitability during that period.

However, this trend was not sustained in the following years. Although the operating ROA remained relatively high in 2020 at 22.42% and in 2019 at 27.07%, there was a noticeable decrease in 2022 to 19.31% and further decline in 2023 to 17.26%. This decline may suggest challenges in maintaining or improving operational efficiency and profitability over those years.

Overall, while Corcept Therapeutics Inc has demonstrated the ability to generate favorable returns on its assets in the past, the recent decrease in operating ROA highlights the importance of closely monitoring and improving operational performance to enhance overall financial health and sustainability.